Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$7.3 -0.05 | -0.68%
07/25/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 36.25M 30.66M 20.91M 22.08M
Cost of Sales 0.00 10.15M 5.12M 13.04M
Gross Operating Profit 36.25M 20.51M 15.79M 9.03M
Selling, General, and Administrative Expenses 30.84M 19.93M 14.82M 10.99M
Research & Development 162.64M 79.44M 50.31M 26.06M
Operating Income before D & A (EBITDA) -157.24M -78.85M -49.34M -28.02M
Depreciation & Amortization 7.20M 4.84M 3.10M 1.65M
Interest Income 660.00K 286.00K 187.00K 165.00K
Other Income - Net -120.00K 615.00K 449.00K 1.02M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -163.90M -82.79M -51.80M -28.48M
Interest Expense 241.00K 157.00K 160.00K 32.00K
Pre-Tax Income -164.14M -82.95M -51.96M -28.51M
Income Taxes 0.00 0.00 25.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -156.94M -82.95M -51.98M -28.51M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -156.94M -82.95M -51.98M -28.51M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -156.94M -82.95M -51.98M -28.51M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-156.94M -82.95M -51.98M -28.51M
Preferred Dividends
Net Income Available To Common -156.94M -82.95M -51.98M -28.51M
Basic EPS from Continuing Ops. -0.60 -0.37 -0.31 -0.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.60 -0.37 -0.31 -0.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.60 -0.37 -0.31 -0.22
Basic Normalized Net Income/Share -0.60 -0.37 -0.31 -0.22
EPS fr Continuing Ops. -0.60 -0.37 -0.31 -0.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.60 -0.37 -0.31 -0.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.60 -0.37 -0.31 -0.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.60 -0.37 -0.31 -0.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter